Colon carcinogenesis in inflammatory bowel disease

Steven H. Itzkowitz, Bruce Greenwald, Stephen Meltzer

Research output: Contribution to journalReview article

Abstract

Colon cancers arising in the setting of chronic inflammatory bowel disease (IBD) share only some of the clinicopathological features with sporadic colon cancers. Whereas much is known about the molecular alterations involved in sporadic colon cancer, less is known in this regard with respect to colitis‐associated neoplasms. Of the phenotypic alterations that have been most widely studied, increases in sialomucin and decreases in sialic acid O‐acetylation appear to correlate with malignant progression in IBD. These mucin alterations, exemplified by sialosyl‐Tn antigen, suggest that small intestinal metaplasia occurs as part of the carcinogenic process. At the molecular genetic level, genomic instability and clonal evolution, as evidenced by abnormal DNA content (aneuploidy) are associated with malignant progression. The activation of specific protooncogenes (k‐ras, c‐src) and the loss or mutation of certain tumor suppressor genes (p53, APC) occur in colitis‐associated colon neoplasms, although the frequency and chronology of these alterations may differ from that of sporadic carcinogenesis. Microsatellite instability also occurs during colitis‐associated carcinogenesis, but mutations in DNA mismatch repair genes often associated with this molecular alteration have not yet been described. Additional research will be required to elucidate the basic pathobiology of carcinogenesis in IBD and to determine how this knowledge can be used to influence clinical management of patients.

Original languageEnglish (US)
Pages (from-to)142-158
Number of pages17
JournalInflammatory Bowel Diseases
Volume1
Issue number2
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Inflammatory Bowel Diseases
Colonic Neoplasms
Colon
Carcinogenesis
Sialomucins
Clonal Evolution
Chronology
Microsatellite Instability
Mutation
DNA Mismatch Repair
Genomic Instability
Metaplasia
Aneuploidy
N-Acetylneuraminic Acid
Mucins
Tumor Suppressor Genes
Molecular Biology
Antigens
DNA
Research

Keywords

  • Allelic deletion
  • APC gene
  • Carbohydrate antigens
  • Carcinogenesis
  • Clonal evolution
  • Colon carcinoma
  • Crohn's colitis
  • c‐src
  • DNA aneuploidy
  • DNA repair
  • k‐ras
  • Lectins
  • Microsatellite instability
  • Mucin
  • Oncogenes
  • O‐acetylation
  • p53 gene
  • Prognostic markers
  • Sialomucin
  • Small intestinal metaplasia
  • Tumor suppressor genes
  • Ulcerative colitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Medicine(all)
  • Gastroenterology

Cite this

Colon carcinogenesis in inflammatory bowel disease. / Itzkowitz, Steven H.; Greenwald, Bruce; Meltzer, Stephen.

In: Inflammatory Bowel Diseases, Vol. 1, No. 2, 1995, p. 142-158.

Research output: Contribution to journalReview article

Itzkowitz, Steven H. ; Greenwald, Bruce ; Meltzer, Stephen. / Colon carcinogenesis in inflammatory bowel disease. In: Inflammatory Bowel Diseases. 1995 ; Vol. 1, No. 2. pp. 142-158.
@article{42cdb15337854bdb9788f6b4113160bc,
title = "Colon carcinogenesis in inflammatory bowel disease",
abstract = "Colon cancers arising in the setting of chronic inflammatory bowel disease (IBD) share only some of the clinicopathological features with sporadic colon cancers. Whereas much is known about the molecular alterations involved in sporadic colon cancer, less is known in this regard with respect to colitis‐associated neoplasms. Of the phenotypic alterations that have been most widely studied, increases in sialomucin and decreases in sialic acid O‐acetylation appear to correlate with malignant progression in IBD. These mucin alterations, exemplified by sialosyl‐Tn antigen, suggest that small intestinal metaplasia occurs as part of the carcinogenic process. At the molecular genetic level, genomic instability and clonal evolution, as evidenced by abnormal DNA content (aneuploidy) are associated with malignant progression. The activation of specific protooncogenes (k‐ras, c‐src) and the loss or mutation of certain tumor suppressor genes (p53, APC) occur in colitis‐associated colon neoplasms, although the frequency and chronology of these alterations may differ from that of sporadic carcinogenesis. Microsatellite instability also occurs during colitis‐associated carcinogenesis, but mutations in DNA mismatch repair genes often associated with this molecular alteration have not yet been described. Additional research will be required to elucidate the basic pathobiology of carcinogenesis in IBD and to determine how this knowledge can be used to influence clinical management of patients.",
keywords = "Allelic deletion, APC gene, Carbohydrate antigens, Carcinogenesis, Clonal evolution, Colon carcinoma, Crohn's colitis, c‐src, DNA aneuploidy, DNA repair, k‐ras, Lectins, Microsatellite instability, Mucin, Oncogenes, O‐acetylation, p53 gene, Prognostic markers, Sialomucin, Small intestinal metaplasia, Tumor suppressor genes, Ulcerative colitis",
author = "Itzkowitz, {Steven H.} and Bruce Greenwald and Stephen Meltzer",
year = "1995",
doi = "10.1002/ibd.3780010208",
language = "English (US)",
volume = "1",
pages = "142--158",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Colon carcinogenesis in inflammatory bowel disease

AU - Itzkowitz, Steven H.

AU - Greenwald, Bruce

AU - Meltzer, Stephen

PY - 1995

Y1 - 1995

N2 - Colon cancers arising in the setting of chronic inflammatory bowel disease (IBD) share only some of the clinicopathological features with sporadic colon cancers. Whereas much is known about the molecular alterations involved in sporadic colon cancer, less is known in this regard with respect to colitis‐associated neoplasms. Of the phenotypic alterations that have been most widely studied, increases in sialomucin and decreases in sialic acid O‐acetylation appear to correlate with malignant progression in IBD. These mucin alterations, exemplified by sialosyl‐Tn antigen, suggest that small intestinal metaplasia occurs as part of the carcinogenic process. At the molecular genetic level, genomic instability and clonal evolution, as evidenced by abnormal DNA content (aneuploidy) are associated with malignant progression. The activation of specific protooncogenes (k‐ras, c‐src) and the loss or mutation of certain tumor suppressor genes (p53, APC) occur in colitis‐associated colon neoplasms, although the frequency and chronology of these alterations may differ from that of sporadic carcinogenesis. Microsatellite instability also occurs during colitis‐associated carcinogenesis, but mutations in DNA mismatch repair genes often associated with this molecular alteration have not yet been described. Additional research will be required to elucidate the basic pathobiology of carcinogenesis in IBD and to determine how this knowledge can be used to influence clinical management of patients.

AB - Colon cancers arising in the setting of chronic inflammatory bowel disease (IBD) share only some of the clinicopathological features with sporadic colon cancers. Whereas much is known about the molecular alterations involved in sporadic colon cancer, less is known in this regard with respect to colitis‐associated neoplasms. Of the phenotypic alterations that have been most widely studied, increases in sialomucin and decreases in sialic acid O‐acetylation appear to correlate with malignant progression in IBD. These mucin alterations, exemplified by sialosyl‐Tn antigen, suggest that small intestinal metaplasia occurs as part of the carcinogenic process. At the molecular genetic level, genomic instability and clonal evolution, as evidenced by abnormal DNA content (aneuploidy) are associated with malignant progression. The activation of specific protooncogenes (k‐ras, c‐src) and the loss or mutation of certain tumor suppressor genes (p53, APC) occur in colitis‐associated colon neoplasms, although the frequency and chronology of these alterations may differ from that of sporadic carcinogenesis. Microsatellite instability also occurs during colitis‐associated carcinogenesis, but mutations in DNA mismatch repair genes often associated with this molecular alteration have not yet been described. Additional research will be required to elucidate the basic pathobiology of carcinogenesis in IBD and to determine how this knowledge can be used to influence clinical management of patients.

KW - Allelic deletion

KW - APC gene

KW - Carbohydrate antigens

KW - Carcinogenesis

KW - Clonal evolution

KW - Colon carcinoma

KW - Crohn's colitis

KW - c‐src

KW - DNA aneuploidy

KW - DNA repair

KW - k‐ras

KW - Lectins

KW - Microsatellite instability

KW - Mucin

KW - Oncogenes

KW - O‐acetylation

KW - p53 gene

KW - Prognostic markers

KW - Sialomucin

KW - Small intestinal metaplasia

KW - Tumor suppressor genes

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84910908238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910908238&partnerID=8YFLogxK

U2 - 10.1002/ibd.3780010208

DO - 10.1002/ibd.3780010208

M3 - Review article

AN - SCOPUS:84910908238

VL - 1

SP - 142

EP - 158

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 2

ER -